Peginterferon alfa-2a and Ribavirin

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Hoffman-La Roche Ltd.

Brand Name:

Pegasys RBV

Project Line:

Reimbursement Review

Project Number:

SR0013-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hepatitis C, chronic

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

October 14, 2004

Recommendation:

List in a similar manner to other interferon plus ribavirin products used in the treatment of chronic hepatitis C.

Last Updated : May 14, 2004